New Partner Spotlight: ALS Therapy Development Institute
ALS Therapy Development Institute (ALS TDI) is a nonprofit biotechnology research organization focused on finding treatments for Amyotrophic Lateral Sclerosis (ALS). It is centered on the belief that ALS is not an incurable disease, just an underfunded one. With over 30 scientists, ALS TDI is the world’s foremost drug discovery center focused solely on ALS.
Orr Group is partnering with ALS TDI to assess its current development infrastructure, capacity and assets and gather the information needed to assist them in preparation for further philanthropic growth which will allow them to continue to enhance their important research in the ALS space.